Join
Live feed
·
PRReleasevia Quantisnow
NovoCure Limited logo

Novocure’s Optune Pax® Receives CE Mark for the Treatment of Locally Advanced Pancreatic Cancer

ByQuantisnow·Wall Street's wire, on your screen.
NVCR· NovoCure Limited
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track NVCR (NovoCure Limited) and more on Quantisnow.